about
The epithelial-mesenchymal transition generates cells with properties of stem cellsMesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancersTwist, a master regulator of morphogenesis, plays an essential role in tumor metastasisBSTA promotes mTORC2-mediated phosphorylation of Akt1 to suppress expression of FoxC2 and stimulate adipocyte differentiationTumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changesFluorinated graphene oxide; a new multimodal material for biological applications.N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration.Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transitionA model for the transcriptional regulation of the CYP2B1/B2 gene in rat liverSlug and Sox9 cooperatively determine the mammary stem cell state.Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypesLoss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasisTowards elucidating the connection between epithelial-mesenchymal transitions and stemnessStability of the hybrid epithelial/mesenchymal phenotype.Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1.Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity.Investigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface protein.GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy.Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer CellsA novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome.The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states.Hybrid 2D nanomaterials as dual-mode contrast agents in cellular imagingGene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.Coupling the modules of EMT and stemness: A tunable 'stemness window' modelExploring a new twist on tumor metastasis.Mathematical modelling of phenotypic plasticity and conversion to a stem-cell state under hypoxia.The evolving portrait of cancer metastasis.EMT-induced metabolite signature identifies poor clinical outcome.Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.FOXC2 regulates the G2/M transition of stem cell-rich breast cancer cells and sensitizes them to PLK1 inhibition.Cell type-specific DNA methylation patterns in the human breastNotch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype.High hardness in the biocompatible intermetallic compound β-Ti3Au.CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties.The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth.
P50
Q24650786-F6B0927D-F8F0-42FA-B3C1-5D7CBF119DEEQ24674085-FD2BE799-42CB-4226-926D-9CD751AEC2C8Q28131703-4FA440C7-D50D-4C95-970F-44E348FD9C87Q28282926-285B2D33-650C-43DA-A2F3-FF401BD50CADQ28539958-1683C218-77C2-464B-81EA-51876325B20FQ30428231-7F295D81-0012-46C1-9951-4BDABB959339Q33721764-C1EB15D7-E0C1-4646-B3C2-C6A2EB86C99BQ33741948-BBA4861C-A2C1-4F51-8548-747867F955BEQ33858315-9B4EDC01-DE17-4005-94BB-8986E0B96CD1Q34030957-00DA10D9-F125-402A-995C-3480D3A782D5Q34100400-C379EB26-F46E-4604-AFC6-2A15C089D3A7Q34133391-288D152C-C141-4EE7-B5DC-18FC3F013139Q34470537-0ED69A41-D9E8-4469-8D11-373A85A51B11Q34519552-326A642C-5687-4D31-8130-84E8C8E61E1EQ34572680-0D6C6C12-4F5F-407B-AA8F-EE64923E875EQ34680041-93EE5B8C-FC04-43BD-B368-BF18E9228FFEQ34755413-2E89900B-9F0B-44CD-BCE8-49672E765762Q35072671-64851118-E178-40B3-BD22-AECBA28500E8Q35204595-6B176B0F-E855-4229-9C5E-448CD894DECFQ35710589-2D852274-5B22-47E5-8F27-C60694B38E2DQ35796943-0212314E-BB1D-4279-A61F-DBECD5BB6554Q36055931-2392CA3E-197E-49A2-90AC-880A6659BE33Q36090969-0B750D65-B467-41B8-8770-F298C1F6220BQ36245556-CD83014E-ACFC-4305-9D3D-624D4B39B6CCQ36406697-711F54B6-863F-40C2-A707-C257FD590461Q36413140-53A6B355-1F38-4D19-92DC-9BFFB6FDB2A7Q36465194-9FCF250D-948D-4E2E-9D88-630DC608DCD0Q36536129-8C3BE9AD-AE46-4F15-A823-63C52AADC227Q36547739-774DAD2F-E3DD-4C90-A2AC-86B77C49133EQ36618962-176E7D0F-D950-4B85-B6CC-8A0F17B13E70Q36665174-7AB0C863-5EF6-4303-B504-6FD74FEC6920Q36698254-F5386054-3006-4B39-AF4A-778492EEC3AAQ36786443-EEA6FAC6-B2D6-44D0-B0FB-969D94F800F8Q36869180-EE0B8F31-89C6-4CF4-92E8-29E6D35AD1C6Q36966739-2F112CA7-0CF5-46DA-80C7-B9D833523AECQ37115307-8454507E-106E-4491-B0AF-1CD8FB8B5F07Q37138668-5D5895AC-461E-4007-9402-1F8788875213Q37180271-86BEF9CA-B7C2-4D54-9B36-F0304FF77705Q37401193-F35E1A69-850B-495D-9A15-69765F04F6F4Q37420968-0DDAB81B-C137-44E7-ABFC-35932EE719DE
P50
description
professor
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sendurai A Mani
@nl
Sendurai A Mani
@sl
Sendurai A. Mani
@en
Sendurai A. Mani
@es
Sendurai A. Mani
@sq
type
label
Sendurai A Mani
@nl
Sendurai A Mani
@sl
Sendurai A. Mani
@en
Sendurai A. Mani
@es
Sendurai A. Mani
@sq
prefLabel
Sendurai A Mani
@nl
Sendurai A Mani
@sl
Sendurai A. Mani
@en
Sendurai A. Mani
@es
Sendurai A. Mani
@sq
P1053
A-7244-2009
P106
P1153
8071423700
P1960
2LwOAQEAAAAJ
P2798
P31
P3829
P3835
sendurai-mani
P496
0000-0002-5918-4276
P569
2000-01-01T00:00:00Z